Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Seeman

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
ACS Chemical Neuroscience|December 10, 2015
Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental TechniquesSerdar Durdagi, Ramin Ekhteiari Salmas, Matthias Stein, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 21, 2008
Cocaine self-administration produces a persistent increase in dopamine D2 High receptorsLisa A Briand, Shelly B Flagel, Philip Seeman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 16, 2007
"Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over timeAnne-Noël Samaha, Philip Seeman, Jane Stewart, et al.
The Journal of Clinical Psychiatry|September 28, 2010
"Extended" antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trialGary Remington, Philip Seeman, Alan Feingold, et al.
Synapse (New York, N.Y.)|July 10, 2009
The dopaminergic stabilizer ASP2314/ACR16 selectively interacts with D2(High) receptorsPhilip Seeman, Kenichi Tokita, Mitsuyuki Matsumoto, et al.
Brain Research. Molecular Brain Research|August 2, 2005
Increased proportion of high-affinity dopamine D2 receptors in rats with excitotoxic damage of the entorhinal cortex, an animal model of schizophreniaTomiki Sumiyoshi, Philip Seeman, Takashi Uehara, et al.
Synapse (New York, N.Y.)|February 17, 2009
Increased dopamine D2High receptors in rats reared in social isolationMadeleine V King, Philip Seeman, Charles A Marsden, et al.
Molecular Brain|September 4, 2010
Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerizationMin Wang, Lin Pei, Paul J Fletcher, et al.
ACS Chemical Neuroscience|December 22, 2016
Biological Insights of the Dopaminergic Stabilizer ACR16 at the Binding Pocket of Dopamine D2 ReceptorRamin Ekhteiari Salmas, Philip Seeman, Busecan Aksoydan, et al.
Biological Psychiatry|February 26, 2008
Less is more: antipsychotic drug effects are greater with transient rather than continuous deliveryAnne-Noël Samaha, Greg E Reckless, Philip Seeman, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
ACS Chemical Neuroscience|December 10, 2015
Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental TechniquesSerdar Durdagi, Ramin Ekhteiari Salmas, Matthias Stein, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 21, 2008
Cocaine self-administration produces a persistent increase in dopamine D2 High receptorsLisa A Briand, Shelly B Flagel, Philip Seeman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 16, 2007
"Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over timeAnne-Noël Samaha, Philip Seeman, Jane Stewart, et al.
The Journal of Clinical Psychiatry|September 28, 2010
"Extended" antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trialGary Remington, Philip Seeman, Alan Feingold, et al.
Synapse (New York, N.Y.)|July 10, 2009
The dopaminergic stabilizer ASP2314/ACR16 selectively interacts with D2(High) receptorsPhilip Seeman, Kenichi Tokita, Mitsuyuki Matsumoto, et al.
Brain Research. Molecular Brain Research|August 2, 2005
Increased proportion of high-affinity dopamine D2 receptors in rats with excitotoxic damage of the entorhinal cortex, an animal model of schizophreniaTomiki Sumiyoshi, Philip Seeman, Takashi Uehara, et al.
Synapse (New York, N.Y.)|February 17, 2009
Increased dopamine D2High receptors in rats reared in social isolationMadeleine V King, Philip Seeman, Charles A Marsden, et al.
Molecular Brain|September 4, 2010
Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerizationMin Wang, Lin Pei, Paul J Fletcher, et al.
ACS Chemical Neuroscience|December 22, 2016
Biological Insights of the Dopaminergic Stabilizer ACR16 at the Binding Pocket of Dopamine D2 ReceptorRamin Ekhteiari Salmas, Philip Seeman, Busecan Aksoydan, et al.
Biological Psychiatry|February 26, 2008
Less is more: antipsychotic drug effects are greater with transient rather than continuous deliveryAnne-Noël Samaha, Greg E Reckless, Philip Seeman, et al.
Pageof 9